Orthofix Medical Inc. (NASDAQ: OFIX) generates robust annual net revenues scaling in the hundreds of millions of dollars, typically reporting total yearly revenues between $700 million and $750 million. This top-line financial performance is driven by global sales across its core business segments, which include spine fixation products, biologics, bone growth therapies, and advanced limb reconstruction hardware utilized by hospitals and surgical centers worldwide.